Original language | English |
---|---|
Pages (from-to) | 1203-1204 |
Number of pages | 2 |
Journal | The Lancet Infectious Diseases |
Volume | 21 |
Issue number | 9 |
DOIs |
|
Publication status | Published - 2 Aug 2021 |
Bibliographical note
Funding Information:DNF reports serving on advisory boards of Seqirus, Sanofi Pasteur, Pfizer, and AstraZeneca, and consulting for the Ontario Nurses Association, Elementary Teachers' Federation of Ontario, JP Morgan-Chase, WE Foundation, and Farallon Capital, outside the submitted work. FXG is supported by the Natural Sciences and Engineering Research Council of Canada and Toronto COVID-19 Action Fund. All other authors declare no competing interests.